Position in MPLT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$115,634,176
+$50,041,464 QoQ
Shares Held
3,226,400
0.0% QoQ
Ownership
6.96%
of shares outstanding
% of Portfolio
15.43%
of 13F equity value
Holder Rank
#2
of 105 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MPLT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FCPM III SERVICES B.V. holds $749,575,144 across 10 Biotechnology names. MPLT ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NAMS |
NewAmsterdam Pharma Co N.V.
|
8,490,353 | $287,738,062 | |
| 2 | MPLT |
MapLight Therapeutics, Inc.
This page
|
3,226,400 | $115,634,176 | |
| 3 | DYN |
Dyne Therapeutics, Inc.
|
3,848,256 | $85,469,765 | |
| 4 | VOR |
Vor Biopharma Inc.
|
4,117,354 | $75,800,487 | |
| 5 | DMRA |
Damora Therapeutics, Inc.
|
2,441,000 | $63,490,410 | |
| 6 | REPL |
Replimune Group, Inc.
|
2,808,368 | $31,088,633 | |
| 7 | CBIO |
Crescent Biopharma, Inc.
|
1,677,852 | $30,201,336 | |
| 8 | AURA |
Aura Biosciences, Inc.
|
4,053,775 | $28,781,802 |
All Filings in MPLT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,634,176 | 3,226,400 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $65,592,712 | 3,226,400 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $56,671,716 | 3,226,400 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||